![First Glance with Jody Vance Podcast](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails.jpg)
819
Downloads
55
Episodes
Canadian broadcasting veteran Jody Vance talks to the leaders of some of North America's most innovative public companies, from tech to e-sports to mining to biotech and beyond. If you're less interested in balance sheets and more intrigued by people, origin stories, and their own investing philosophies, First Glance should be your first podcast every morning. Subscribe today!
Episodes
![Game On Entertainment Technologies (GET.C) CEO Matt Bailey on driving content engagement (Ep 62) First Glance with Jody Vance](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Monday Jul 26, 2021
Monday Jul 26, 2021
Matt Bailey, Game On Technologies (GET.C), talks about the potential of engaging content consumers through gamifying content with social interaction as well as prizes and polls, giving users an enhanced experience while developing a stronger relationship between content providers such as sports teams, networks and entertainment events, and their audience. Listen in!
![Bioasis Technologies (TSX.V: BTI) (OTCQB: BIOAF) CEO, Deborah Rathjen on the blood-brain barrier (Ep 44)](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Friday Jul 09, 2021
Friday Jul 09, 2021
Deborah Rathjen, CEO of Bioasis Technologies (BTI.V) talks about the company's ground-breaking xB3 platform which allows therapeutic drugs to pass through the seemingly impenetrable blood-brain barrier, providing an effective treatment methodology for such neurological disorders as Alzheimer's disease, Lewy Body Dementia and Parkinson's. In short, Bioasis' final frontier solution could very well revolutionize medical science, potentially helping to heal the one billion people suffering from neurological disorders worldwide. Tune in!
![Biovaxys (BIOV.C) Founder & CEO James Passin talks about their tech, Covid & cancer treatment (Ep56)](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Monday Jul 05, 2021
Monday Jul 05, 2021
In this show, Vancouver-based sportscast icon, Rob Fai, fills in for Jody Vance to talk to Biovaxys Founder and CEO, James Passin. They talk about Biovaxys' journey before going public and what they have planned ahead regarding solutions to Covid and cancer treatment.
![Diagnos (ADK.V) President & CEO Andre Larente with updates on IRIS The Visual Group deal (Ep 55)](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Monday Jul 05, 2021
Monday Jul 05, 2021
Vancouver broadcasting icon, Jody Vance, speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an update on the company's recent agreement with IRIS the Vision Group and it's importance to optometrists and Canadians. Tune in!
For more details: https://equity.guru/2021/06/10/diagnos-adk-v-latest-agreement-with-iris-the-vision-group-aims-to-help-canadians-see-better/
![Mountain Valley MD (MVMD.C) CEO, Dennis Hancock talks about Ivermectin, Covid & cancer (Ep 54)](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Monday Jul 05, 2021
Monday Jul 05, 2021
Much-loved Vancouver broadcasting icon, Jody Vance, speaks with Dennis Hancock, president and CEO of Mountain Valley MD (MVMD.C) to get an update on the company's rocketing market cap, plans for a new FDA pathway for its Ivermectin solution for Covid and what shareholders can expect to see over the next 12 months. Tune in!
![Nouveau Monde Graphite (NOU.V) CEO, Eric Desaulniers & their all-electric graphite mine (Ep 53)](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Monday Jul 05, 2021
Monday Jul 05, 2021
Vancouver broadcasting icon, Jody Vance, talks to Nouveau Monde Graphite CEO, Eric Desaulniers about the transition to a green future through sustainable Zero-Carbon SolutionsTM and the mission to produce the greenest advanced graphite materials with a carbon-neutral footprint for a sustainable world. The Company is developing advanced carbon-neutral graphite-based material solutions for the growing lithium-ion and fuel cell markets. Listen in!
![DMG Blockchain Solutions (DMGI.V) CEO, Sheldon Bennett on their model, solutions & Bitcoin (Ep 52)](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Monday Jul 05, 2021
Monday Jul 05, 2021
Much-loved Vancouver broadcasting icon, Jody Vance, speaks with DMG Blockchain Solutions CEO & Director, Sheldon Bennett. Bennett has over 20 years of management experience leading international companies, including PwC, Ernst & Young, Baker & McKenzie, and Cisco Systems before founding DMG Blockchain Solutions. In this episode, they go over DMG Blockchain Solutions' vision and role in the future of cryptocurrency and its mining industry.
![Core One Labs (COOL) CEO Joel Shacker gives an update on their biosynthetic psilocybin formulation ( EP 51) FG/JV](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Tuesday May 04, 2021
Tuesday May 04, 2021
Much-loved Vancouver radio personality Jody Vance connects with Joel Shacker, CEO of Core One Labs, to discuss biosynthetic psilocybin, their novel delivery system, and plans for the future. Subscribe and Tune in!
![Mountain Valley MD (MVMD) CEO Dennis Hancock give an update on the progress of their ivermectin trials (EP 50) FG/JV](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Thursday Apr 22, 2021
Thursday Apr 22, 2021
Much-loved Vancouver broadcasting icon, Jody Vance, speaks with Dennis Hancock, president and CEO of Mountain Valley MD (MVMD.C) to get an update on the company's rocketing market cap, plans for a new FDA pathway for its Ivermectin solution for Covid, and what shareholders can expect to see over the next 12 months. Tune in and subscribe!
![Valeo Pharma (VPH) President and CEO Steve Saviuk updates us on their Novartis Agreement (EP 48) FG/JV](https://pbcdn1.podbean.com/imglogo/image-logo/11403578/First-Glance-Podcast-Thumbnails_300x300.jpg)
Thursday Apr 22, 2021
Thursday Apr 22, 2021
Prominent Vancouver radio personality Jody Vance speaks with Valeo Pharma President and CEO Steve Saviuk about their Novartis agreement and their latest round of financing. Subscribe and Tune in!